Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT00368095

Rajavithi Health Promotion Project (Population Base Cohort)

Metabolic Syndrome (hypertension, diabetes mellitus, obesity, cerebrovascular-cardiovascular disease) In Community Survey was performed in central Bangkok.

Prospective Cohort and intensive educated intervention (health promotion program in specific high risk groups) were performed. The aim of the study is to identify high risk patients who can develop serious complications from metabolic syndrome. An analysis of health outcomes in multiple dimensions will be performed.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 16 years or more
  • Informed consent
  • Living in selected community (Health Promotion area of Rajavithi Hospital)

Treatment and study plan

Intensive Education for Metabolic Syndrome Patients

Behavioral

Excercise, Intensive diatary program

Other names: Patient with Metabolic Syndrome will be advised fro improve health status and genetic test will be apply

Sponsors and collaborators

Lead sponsor

Department of Medical Services Ministry of Public Health of Thailand

Other Gov

Collaborators

  • U.S. Department of Education

Registry information

Official study title

The Rajavithi Prospective Cohort Study on Community's Member Health (HPH-cohort Study)

Important dates

Study start
2006
Primary completion
2026
Study completion
2026
First posted
Aug 24, 2006
Registry last updated
May 6, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.